Immunohistochemistry (IHC) is one of the most valuable techniques used in pathology laboratories to identify specific proteins within tissue samples. It plays a significant role in diagnosing diseases, especially different types of cancer, by allowing pathologists to observe the presence and distribution of biomarkers in cells. However, the accuracy of IHC results depends on more than just high-quality antibodies and laboratory equipment. Proper quality control is essential, and this is where IHC controls become indispensable. Among the most important quality assurance measures are internal and external IHC controls. Understanding how these controls function helps laboratories maintain consistent, reliable, and clinically meaningful results.
What Are IHC Controls?
IHC controls are reference samples or tissue components used during immunohistochemical staining to verify that every step of the testing process is functioning correctly. Controls ensure that staining procedures, antibodies, reagents, and laboratory techniques produce accurate and reproducible results. Without appropriate controls, false-positive or false-negative findings may occur, potentially leading to incorrect diagnoses and inappropriate treatment decisions.
Internal and external controls serve different purposes, but together they provide a comprehensive evaluation of the staining process.
What Are Internal IHC Controls?
Internal IHC controls are naturally occurring positive or negative cells located within the same patient tissue section being examined. These cells are expected to express the target antigen consistently and therefore serve as built-in quality indicators during staining.
Because they exist within the patient's own specimen, internal controls undergo the exact same processing, fixation, antigen retrieval, and staining conditions as the tissue of interest. This makes them particularly useful for assessing whether the staining procedure has worked properly.
For example, when staining breast tissue for hormone receptors, normal epithelial cells that are known to express the receptor can act as internal positive controls. If these cells stain appropriately while the tumor cells do not, the pathologist can be more confident that the tumor truly lacks the marker rather than assuming the staining process failed.
Advantages of Internal Controls
Internal controls offer several important benefits:
- They experience identical laboratory processing as the target tissue.
- They help detect problems caused by poor tissue fixation.
- They reduce uncertainty in result interpretation.
- They provide immediate verification of staining quality within every slide.
- They improve confidence in negative staining results.
Because internal controls reflect the exact condition of the patient's specimen, many pathologists consider them among the most valuable quality indicators available.
What Are External IHC Controls?
External IHC controls are separate tissue sections prepared alongside the patient specimen. These control tissues are selected because they have well-established positive or negative expression of the target antigen.
External controls are stained simultaneously with patient samples using the same antibodies, reagents, and protocols. Their primary purpose is to verify that the staining procedure, antibody performance, and laboratory reagents are functioning correctly.
For example, if a laboratory performs HER2 staining, a known HER2-positive tissue sample may be included as an external positive control. Likewise, a tissue known to lack HER2 expression can serve as a negative control.
If the external positive control fails to stain correctly, laboratory personnel immediately know there may be a technical problem affecting the entire staining run.
Advantages of External Controls
External controls provide several important advantages:
- They validate antibody performance.
- They monitor reagent quality.
- They detect technical failures in staining runs.
- They ensure consistency across multiple batches.
- They support laboratory accreditation and quality assurance requirements.
External controls are especially valuable when evaluating newly introduced antibodies or modified staining protocols.
Key Differences Between Internal and External Controls
Although both control types support quality assurance, they differ in several important ways.
Internal controls are present within the patient's tissue, whereas external controls are separate reference tissues prepared independently. Internal controls undergo identical fixation and processing as the patient's specimen, making them excellent indicators of specimen-specific quality. External controls mainly verify that laboratory procedures and reagents are working correctly across the staining run.
Internal controls help interpret individual patient results, while external https://www.bosterbio.com/services/assay-services/ihc-histology-services/analyzing-ihc-data-from-halo-to-pathologist-review monitor the overall performance of the staining system. Using both together provides the highest level of confidence in diagnostic accuracy.
Why Both Types of Controls Are Necessary
Neither internal nor external controls alone can guarantee completely reliable IHC results.
A perfectly stained external control cannot identify poor fixation in an individual patient sample. Likewise, internal controls cannot detect widespread problems affecting reagent quality or antibody performance across an entire batch.
By combining both control types, laboratories can identify technical errors, specimen-related issues, and reagent failures before diagnostic interpretations are made.
This layered quality assurance approach minimizes diagnostic errors and improves confidence in pathology reports.
Common Challenges
Although internal and external controls are extremely useful, laboratories may encounter several challenges.
Internal controls may not always be present in every tissue specimen. Some samples lack sufficient normal tissue to serve as reliable controls, requiring greater reliance on external control tissues.
External controls, on the other hand, may differ from patient specimens in fixation time or tissue processing. These differences can occasionally affect staining intensity, making careful interpretation necessary.
Proper control selection, standardized protocols, and experienced laboratory personnel help overcome these limitations.
Best Practices for Using Internal and External Controls
Laboratories should follow established quality assurance practices to maximize the value of IHC controls. These include:
- Include appropriate external positive and negative controls with every staining run.
- Carefully identify available internal controls during slide interpretation.
- Use standardized fixation and staining procedures.
- Monitor antibody and reagent performance regularly.
- Document all quality control results for laboratory records.
- Participate in external quality assessment programs.
- Train laboratory staff in proper control interpretation.
Consistent adherence to these practices helps maintain reliable and reproducible IHC testing.
Conclusion
Understanding internal and external IHC controls is fundamental to producing accurate immunohistochemistry results. Internal controls provide specimen-specific confirmation that staining has worked correctly, while external controls verify the overall performance of antibodies, reagents, and laboratory procedures. Together, they create a comprehensive quality assurance system that supports reliable diagnoses and improves patient care. As immunohistochemistry continues to expand in diagnostic pathology and precision medicine, the proper use of both internal and external controls remains an essential component of every high-quality laboratory workflow.
